| Year |
Citation |
Score |
| 2019 |
Jonasch E, Park EK, Thamake S, Hirmand M, Linehan WM, Srinivasan R. An open-label phase II study to evaluate PT2977 for the treatment of von Hippel-Lindau disease-associated renal cell carcinoma. Journal of Clinical Oncology. 37: TPS680-TPS680. DOI: 10.1200/Jco.2019.37.7_Suppl.Tps680 |
0.314 |
|
| 2016 |
Kokate RA, Chaudhary P, Sun X, Thamake SI, Maji S, Chib R, Vishwanatha JK, Jones HP. Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy. Nanomedicine (London, England). PMID 26892440 DOI: 10.2217/Nnm.15.213 |
0.597 |
|
| 2015 |
Kokate RA, Thamake SI, Chaudhary P, Mott B, Raut SL, Vishwanatha JK, Jones H. Erratum: Enhancement of anti-tumor effect of particulate vaccine delivery system by 'Bacteriomimetic' (Nanomedicine (2015) 10:6 (915-929)) Nanomedicine: Nanotechnology, Biology and Medicine. 10. PMID 26008199 DOI: 10.2217/Nnm.15.55 |
0.532 |
|
| 2015 |
Kokate RA, Thamake SI, Chaudhary P, Mott B, Raut S, Vishwanatha JK, Jones HP. Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticles. Nanomedicine (London, England). 10: 915-29. PMID 25867857 DOI: 10.2217/Nnm.14.144 |
0.615 |
|
| 2014 |
Chaudhary P, Thamake SI, Shetty P, Vishwanatha JK. Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies British Journal of Cancer. 111: 2328-2341. PMID 25321192 DOI: 10.1038/Bjc.2014.542 |
0.571 |
|
| 2013 |
Kokate R, Thamake S, Jones H, Vishwanatha J, Mott B. Abstract 1270: Mimicking infection for immunotherapy against breast cancer - fooling the immune system. Cancer Research. 73: 1270-1270. DOI: 10.1158/1538-7445.Am2013-1270 |
0.566 |
|
| 2013 |
Mott B, Thamake S, Vishwanatha J, Jones HP. Intranasal delivery of nanoparticle-based vaccine increases protection against S. pneumoniae Journal of Nanoparticle Research. 15. DOI: 10.1007/S11051-013-1646-X |
0.572 |
|
| 2012 |
Shetty PK, Thamake SI, Biswas S, Johansson SL, Vishwanatha JK. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer. Plos One. 7: e44299. PMID 22957061 DOI: 10.1371/Journal.Pone.0044299 |
0.551 |
|
| 2012 |
Ondricek AJ, Kashyap AK, Thamake SI, Vishwanatha JK. A comparative study of phytoestrogen action in mitigating apoptosis induced by oxidative stress. In Vivo (Athens, Greece). 26: 765-75. PMID 22949589 |
0.459 |
|
| 2012 |
Thamake SI, Raut SL, Gryczynski Z, Ranjan AP, Vishwanatha JK. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials. 33: 7164-73. PMID 22795543 DOI: 10.1016/J.Biomaterials.2012.06.026 |
0.584 |
|
| 2012 |
Shetty PK, Thamake SI, Biswas S, Johansson SL, Vishwanatha JK. Correction: Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer Plos One. 7. DOI: 10.1371/annotation/ba62ae01-bf71-46c1-a45c-32692d3bb4ab |
0.484 |
|
| 2011 |
Ranjan AP, Zeglam K, Mukerjee A, Thamake S, Vishwanatha JK. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging. Nanotechnology. 22: 295104. PMID 21693801 DOI: 10.1088/0957-4484/22/29/295104 |
0.578 |
|
| 2011 |
Valapala M, Thamake SI, Vishwanatha JK. A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. Journal of Cell Science. 124: 1453-64. PMID 21486955 DOI: 10.1242/Jcs.079236 |
0.502 |
|
| 2011 |
Thamake SI, Raut SL, Ranjan AP, Gryczynski Z, Vishwanatha JK. Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy. Nanotechnology. 22: 035101. PMID 21149963 DOI: 10.1088/0957-4484/22/3/035101 |
0.603 |
|
| Show low-probability matches. |